2026 · Frontiers in oncology · open access
Comparative performance of hrHPV testing and PAX1/ZNF671 methylation in triaging women with abnormal cytology: a study of paired urine, vaginal and cervical scrape samples
Wang et al.
The finding, in our words
In women with abnormal cytology, hrHPV testing and PAX1/ZNF671 methylation were assessed across paired self-collected urine and vaginal samples versus clinician cervical scrapes. Methylation markers showed high area under the ROC curve for CIN3+ and strong correlation with lesion severity, and the optimal PAX1/ZNF671 panel achieved high sensitivity for CIN2+ in cervical samples but lower sensitivity in urine and vaginal samples, indicating cervical samples are optimal for methylation testing while urine and vaginal self-collection may be useful for hrHPV triage.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.